US 12,358,940 B2
Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
Günter Schabert, Goldach (CH); Urs Spitz, St. Gallen (CH); Aysel Soydemir, Rorschach (CH); and Iris Zimmermann, Bregenz (AT)
Assigned to Biosynth AG, Staad (CH)
Filed by Biosynth AG, Staad (CH)
Filed on Nov. 27, 2024, as Appl. No. 18/963,281.
Application 18/963,281 is a continuation of application No. 17/576,699, filed on Jan. 14, 2022.
Application 17/576,699 is a continuation of application No. PCT/EP2020/070451, filed on Jul. 20, 2020.
Claims priority of application No. 19187314 (EP), filed on Jul. 19, 2019; and application No. 19206542 (EP), filed on Oct. 31, 2019.
Prior Publication US 2025/0092079 A1, Mar. 20, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. C07H 19/048 (2006.01); C07H 1/06 (2006.01)
CPC C07H 19/048 (2013.01) [C07H 1/06 (2013.01)] 21 Claims
 
1. A crystalline form of nicotinamide-β-D-ribofuranoside hydrogen tartrate.